4596
Kubota Pharmaceutical Holdings Co.,Ltd.
窪田製薬ホールディングス
- Industry
- Pharmaceutical
- Market
- Growth
- Accounting standards
- IFRS
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Dec 2021
-
Dec 2022
8,254
Dec 2023
39,887
Dec 2024
27,189
Dec 2025
21,335
Operating profit(thousand JPY)
Dec 2021
-2,584,705
Dec 2022
-2,038,020
Dec 2023
-1,504,006
Dec 2024
-1,345,491
Dec 2025
-894,855
Operating profit margin(%)
Dec 2021
-
Dec 2022
-24,691.3
Dec 2023
-3,770.67
Dec 2024
-4,948.66
Dec 2025
-4,194.31
Profit before tax(thousand JPY)
Dec 2021
-2,616,451
Dec 2022
-2,015,906
Dec 2023
-1,489,602
Dec 2024
-1,332,852
Dec 2025
-676,253
Profit(thousand JPY)
Dec 2021
-2,616,451
Dec 2022
-2,015,906
Dec 2023
-1,489,602
Dec 2024
-1,332,852
Dec 2025
-676,253
Total assets(thousand JPY)
Dec 2021
4,832,564
Dec 2022
4,419,755
Dec 2023
3,016,840
Dec 2024
1,541,907
Dec 2025
1,979,457
Cash and cash equivalents(thousand JPY)
Dec 2021
3,977,312
Dec 2022
4,048,969
Dec 2023
2,767,639
Dec 2024
1,454,908
Dec 2025
1,918,615
Cash flows from operating activities(thousand JPY)
Dec 2021
-2,513,583
Dec 2022
-2,086,695
Dec 2023
-1,335,939
Dec 2024
-1,195,075
Dec 2025
-583,000
Cash flows from investing activities(thousand JPY)
Dec 2021
3,562,579
Dec 2022
505,159
Dec 2023
-45,033
Dec 2024
-43,057
Dec 2025
-3,652
Cash flows from financing activities(thousand JPY)
Dec 2021
171,424
Dec 2022
1,446,787
Dec 2023
96,581
Dec 2024
-88,273
Dec 2025
1,065,666
Return on equity(%)
Dec 2021
-51.6
Dec 2022
-49.8
Dec 2023
-45.2
Dec 2024
-66
Dec 2025
-42.2
Equity ratio(%)
Dec 2021
85.9
Dec 2022
89.4
Dec 2023
87.7
Dec 2024
90.1
Dec 2025
91.6
Earnings per share(JPY per share)
Dec 2021
-57.46
Dec 2022
-40.92
Dec 2023
-26.79
Dec 2024
-23.65
Dec 2025
-10.59
Net assets per share(JPY per share)
Dec 2021
90.55
Dec 2022
72.31
Dec 2023
47.21
Dec 2024
24.48
Dec 2025
15.72
Dividend per share(-)
Dec 2021
-
Dec 2022
-
Dec 2023
-
Dec 2024
-
Dec 2025
-
Payout ratio(-)
Dec 2021
-
Dec 2022
-
Dec 2023
-
Dec 2024
-
Dec 2025
-
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.